$5.5 million investment in the health of Australian newborns

$5.5 million investment in the health of Australian newborns

13 Aug 2024

The University of New South Wales will receive funding under the MRFF’s National Critical Research Infrastructure initiative to:

  • establish a platform that can screen newborns for illnesses such as biotinidase deficiency, haemophilia, cystic fibrosis, spinal muscular atrophy and severe combined immunodeficiency
  • undertake a 12-month research trial of the platform in Queensland.

Read the media release for more information.

Learn about the MRFF.